deltatrials
Completed OBSERVATIONAL NCT02226874

Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation

A Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation

Sponsor: National Cancer Institute (NCI)

Conditions Radiation Exposure
Updated 20 times since 2017 Last updated: Dec 11, 2019 Started: Aug 26, 2014 Primary completion: May 31, 2016 Completion: May 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Radiation Exposure, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 20 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Apr 2018 · 10 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~May 2019 · 8 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2020 — Jan 2021 [monthly]

    Completed

  5. Dec 2019 — Jan 2020 [monthly]

    Completed

▶ Show 15 earlier versions

  1. Nov 2019 — Dec 2019 [monthly]

    Completed

  2. Oct 2019 — Nov 2019 [monthly]

    Completed

  3. Sep 2019 — Oct 2019 [monthly]

    Completed

  4. Aug 2019 — Sep 2019 [monthly]

    Completed

  5. Jul 2019 — Aug 2019 [monthly]

    Completed

  6. Jun 2019 — Jul 2019 [monthly]

    Completed

  7. May 2019 — Jun 2019 [monthly]

    Completed

  8. Sep 2018 — May 2019 [monthly]

    Completed

  9. Jul 2018 — Sep 2018 [monthly]

    Completed

  10. Jun 2018 — Jul 2018 [monthly]

    Completed

  11. May 2018 — Jun 2018 [monthly]

    Completed

  12. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  13. Jun 2017 — Apr 2018 [monthly]

    Completed NA

  14. May 2017 — Jun 2017 [monthly]

    Completed NA

  15. Jan 2017 — May 2017 [monthly]

    Completed NA

    First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations